Cerebral embolization: prospective clinical analysis of 42 cases.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000927:Anticonvulsants / Q000627:therapeutic use; D001014:Aortic Aneurysm / Q000150:complications; D001921:Brain / Q000098:blood supply; D001929:Brain Edema / Q000188:drug therapy; D002340:Carotid Artery Diseases / Q000150:complications; D002561:Cerebrovascular Disorders / Q000209:etiology; D002648:Child; D003331:Coronary Vessels / Q000473:pathology; D003975:Diazepam / Q000627:therapeutic use; D005260:Female; D005990:Glycerol / Q000627:therapeutic use; D006331:Heart Diseases / Q000150:complications; D006350:Heart Valve Prosthesis / Q000009:adverse effects; D006801:Humans; D007238:Infarction / Q000188:drug therapy; D002542:Intracranial Embolism and Thrombosis / Q000175:diagnosis / Q000453:epidemiology* / Q000209:etiology / Q000401:mortality / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D009994:Osmolar Concentration; D010208:Papaverine / Q000627:therapeutic use; D011446:Prospective Studies
D000927:Anticonvulsants; D010208:Papaverine; D005990:Glycerol; D003975:Diazepam